vsk_banner

Research/art/teacher profile of a person

The name of the university:
Pavol Jozef Šafárik University in Košice
The seat of the university:
Šrobárova 2, 041 80 Košice
The name of the faculty:
Faculty of Science
The seat of the faculty:
Šrobárova 2, 040 01 Košice
I. - Basic information
I.1 - Surname
Bojková
I.2 - Name
Bianka
I.3 - Degrees
assoc. prof.
I.4 - Year of birth
1974
I.5 - Name of the workplace
University of P.J.Šafárik in Košice, Faculty of Science, Institute of Biology and Ecology
I.6 - Address of the workplace
Šrobárová 2, 041 54 Košice
I.7 - Position
associate professor
I.8 - E-mail address
bianka.bojkova@upjs.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/15393
I.10 - Name of the study field in which a person works at the university
Biology
I.11 - ORCID iD
0000-0002-6806-8656
II. - Higher education and further qualification growth
II.1 - First degree of higher education
II.a - Name of the university or institution
University of P.J.Šafárik in Košice, Faculty of Science
II.b - Year
1996
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
University of P.J.Šafárik in Košice, Faculty of Science
II.b - Year
1998
II.c - Study field and programme
Biology, Animal and Human Physiology
II.3 - Third degree of higher education
II.a - Name of the university or institution
University of P.J.Šafárik in Košice, Faculty of Science
II.b - Year
2002
II.c - Study field and programme
Animal Physiology 15-17-9
II.4 - Associate professor
II.a - Name of the university or institution
University of P.J.Šafárik in Košice, Faculty of Science
II.b - Year
2016
II.c - Study field and programme
4.2.1 Biology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)
III. - Current and previous employment
III.a - Occupation-positionIII.b - InstitutionIII.c - Duration
associate professorUniversity of P.J.Šafárik in Košice, Faculty of Science1.5 2016 -
assistant professorUniversity of P.J.Šafárik in Košice, Faculty of Science1.1 2006 - 1.5 2016
lecturerUniversity of P.J.Šafárik in Košice, Faculty of Science1.9 2002 - 31.12 2005
IV. - Development of pedagogical, professional, language, digital and other skills
IV.a - Activity description, course name, otherIV.b - Name of the institutionIV.c - Year
Complemenary pedagogical programmeUniversity of P.J. Šafárik in Košice2004
State exam from English languageLanguage school in Prešov1992
V. - Overview of activities within the teaching career at the university
V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile courseV.1.b - Study programmeV.1.c - DegreeV.1.d - Field of study
Animal PhysiologyZoology and Animal Physiology2, 3Biology
Animal and Human EcophysiologyZoology and Animal Physiology2Biology
Experimental OncologyZoology and Animal Physiology3Biology
Environmental PhysiologyZoology and Animal Physiology3Biology
Comparative Animal PhysiologyZoology and Animal Physiology2Biology
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programmeV.2.b - DegreeV.2.c - Field of study
Zoology and Animal Physiology2Biology
Zoology and Animal Physiology3Biology
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
V.4.c - Dissertation (third degree)
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
19
V.4.b - Diploma (second degree)
14
V.4.c - Dissertation (third degree)
V.5 - Overview of other courses taught in the current academic year according to study programmes
VI. - Overview of the research/artistic/other outputs
VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
136
VI.1.b - Over the last six years
14
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
59
VI.1.b - Over the last six years
14
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
VI.1.b - Over the last six years
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
646 (bez autocitácií, k 1.8 2023)
VI.1.b - Over the last six years
124 (without autocitations, august 2023)
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
VI.1.b - Over the last six years
VI.2 - The most significant research/artistic/other outputs

ADC Kubatka P., Ahlers I., Ahlersová E., Adámeková E., Luk P., Bojková B., Marková M. Chemoprevention of mammary carcinogenesis in female rats by rofecoxib, Cancer Lett. 202 (2003), 131-136

ADD Bojková B., Orendáš P., Garajová M., Kassayová M., Kútna V., Ahlersová E., Ahlers I. Metformin in chemically-induced mammary carcinogenesis in rats. Neoplasma 56 (2009), 267-272

ADC Bojková B., Garajová M., Kajo K., Péč M., Kubatka P., Kassayová M., Kisková T., Orendáš P., Ahlersová E., Ahlers I. Pioglitazone in chemically induced mammary carcinogenesis in rats. Eur. J. Cancer Prev. 19 (2010), 379-384

ADC Bojková B., Kajo K., Kisková T., Kubatka P., Žúbor P., Solár P., Péč M., Adamkov M. Metformin and melatonin inhibit DMBA-induced mammary tumorigenesis in rats fed a high-fat diet. Anti-Cancer Drugs 29 (2018) 128-135

ADC Bojková B., Winklewski P.J., Wszedybyl-Winklewska M. Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence. Int. J. Mol. Sci. 21 (2020), 4114

VI.3 - The most significant research/artistic/other outputs over the last six years

ADC Solár P., Sačková V., Hrčková G., Demečková V., Kassayová M., Bojková B., Mudroňová D., Gancarčíková S., Jendželovský R., Fedoročko P. Antitumor effect of the combination of manumycin A and immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model. Oncol. Rep. 37 (2017), 368-378

ADC Bojková B., Kajo K., Kisková T., Kubatka P., Žúbor P., Solár P., Péč M., Adamkov M. Metformin and melatonin inhibit DMBA-induced mammary tumorigenesis in rats fed a high-fat diet. Anticancer Drugs 29 (2018), 128-135

ADC Bojková B., Kubatka P., Qaradakhi T., Zulli A., Kajo K. Melatonin may increase anticancer potential of pleiotropic drugs. Int. J. Mol. Sci. 19 (2018), 3910

ADC Bojková B., Winklewski P.J., Wszedybyl-Winklewska M. Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence. Int. J. Mol. Sci. 21 (2020), 4114

Demeckova V., Mudronova D., Gancarcikova S., Kubatka P., Kajo K., Kassayova M., Bojkova B., Adamkov M., Solár P. 5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN. Int. J. Mol. Sci. 23 (2022), 6374

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

ADC Bojková B., Winklewski P.J., Wszedybyl-Winklewska M. Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence. Int. J. Mol. Sci. 21 (2020), 4114

  1. Bailén M., Bressa C., Martínez-López S., González-Soltero R., Montalvo Lominchar M.G., San Juan C., et al. Microbiota Features Associated With a High-Fat/Low-Fiber Diet in Healthy Adults. Front. Nutr. 7 (2020), 583-608
  2. Morales M., Xue X. Targeting iron metabolism in cancer therapy. Theranostics 11 (2021), 8412-29
  3. Prendeville H., Lynch L. Diet, lipids, and antitumor immunity. Cell. Mol. Immunol. 19 (2022), 432-444
  4. Yadav A.K., Lee M.C., Lucero M.Y., Su S., Reinhardt C.J., Chan J. Activity-Based NIR Bioluminescence Probe Enables Discovery of Diet-Induced Modulation of the Tumor Microenvironment via Nitric Oxide. ACS Cent. Sci. 27 (2022), 461-472
  5. Yang K., Wang X., Song C., He Z., Wang R., Xu Y., et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics 13 (2023), 1774-1808.

ADC Bojková B., Kajo K., Kisková T., Kubatka P., Žúbor P., Solár P., Péč M., Adamkov M. Metformin and melatonin inhibit DMBA-induced mammary tumorigenesis in rats fed a high-fat diet. Anticancer Drugs 29 (2018), 128-135

  1. Abutaha N., Nasr F.A., Al-Zharani M., Alqahtani A.S., Noman O.M., Mubarak M., et al. Effects of Hexane Root Extract of Ferula hermonis Boiss. on Human Breast and Colon Cancer Cells: An In Vitro and In Vivo Study. Biomed. Res. Int. 15 (2019), 3079895
  2. De A., Kuppusamy G. Metformin in breast cancer: preclinical and clinical evidence. Curr. Probl. Cancer. 44 (2020), 100488
  3. Kawakita E., Yang F., Kumagai A., Takagaki Y., Kitada M., Yoshitomi Y., et al. Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling. Mol. Cancer Res. 19 (2021), 61-73
  4. Shih Y.H., Chiu K.C., Wang T.H., Lan W.C., Tsai B.H., Wu L.J., et al. Effects of melatonin to arecoline-induced reactive oxygen species production and DNA damage in oral squamous cell carcinoma. J. Formos. Med. Assoc. 120 (2021), 668-678.
  5. Beyaz S., Aslan A., Gok O., Uslu H., Agca C.A., Ozercan I.H. In vivo, in vitro and in silico anticancer investigation of fullerene C60 on DMBA induced breast cancer in rats. Life Sci. 15 (2022), 120281

ADC Solár P., Sačková V., Hrčková G., Demečková V., Kassayová M., Bojková B., Mudroňová D., Gancarčíková S., Jendželovský R., Fedoročko P. Antitumor effect of the combination of manumycin A and immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model. Oncol. Rep. 37 (2017), 368-378

  1. Kobayashi H. Cancer Chemotherapy Specific to Acidic Nests. Cancers (Basel) 20 (2017), 9040036
  2. Cole D.W., Svider P.F., Shenouda K.G., Lee P.B., Yoo N.G., McLeod T.M., et al. Targeting the unfolded protein response in head and neck and oral cavity cancers. Exp Cell Res. 382 (2019), 111386
  3. Lorenzo-Anota H.Y., Martínez-Torres A.C., Scott-Algara D., Tamez-Guerra R.S., Rodríguez-Padilla C. Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT-CRP Induces Selective ROS-Dependent Apoptosis in T-Acute Lymphoblastic Leukemia Cell Lines. J. Oncol. 8 (2020), 1598503
  4. Macias A.E., Guaní-Guerra E.Transfer Factor: Myths and Facts. Arch Med Res. 51 (2020), 613-622
  5. Sojka D.R., Hasterok S., Vydra N., Toma-Jonik A., Wieczorek A., Gogler-Pigłowska A., et al. Inhibition of the Heat Shock Protein A (HSPA) Family Potentiates the Anticancer Effects of Manumycin A. Cells 7 (2021), 1418

ADC Bojková B., Garajová M., Kajo K., Péč M., Kubatka P., Kassayová M., Kisková T., Orendáš P., Ahlersová E., Ahlers I. Pioglitazone in chemically induced mammary carcinogenesis in rats. Eur. J. Cancer Prev. 19 (2010), 379-384

  1. Dobson M.E., Diallo-Krou E., Grachtchouk V., Yu J., Colby L.A., Wilkinson J.E., et al. Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma. Endocrinology 152 (2011), 4455-65
  2. Mughal A., Kumar D., Vikram A. Effects of Thiazolidinediones on metabolism and cancer: Relative influence of PPARγ and IGF-1 signaling. Eur. J. Pharmacol. 5 (2015), 217-25
  3. Li T.D., Zeng Z.H. Adiponectin as a potential therapeutic target for the treatment of restenosis. Biomed. Pharmacother. 101 (2018), 798-804
  4. Bae W.J., Ahn J.M., Byeon H.E., Kim S., Lee D. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin. J. Exp. Clin. Cancer Res. 5 (2019), 484
  5. Kim D.H., Ahn J., Suh Y., Ziouzenkova O., Lee J.W., Lee K. Retinol Binding Protein 7 Promotes Adipogenesis in vitro and Regulates Expression of Genes Involved in Retinol Metabolism. Front. Cell. Dev. Biol. 14 (2022), 876031

ADD Bojková B., Orendáš P., Garajová M., Kassayová M., Kútna V., Ahlersová E., Ahlers I. Metformin in chemically-induced mammary carcinogenesis in rats. Neoplasma 56 (2009), 267-272

  1. Jalving M., Gietema J.A., Lefrandt J.D., Jong S.D., Reyners A.K.L., Gans R.O.B., et al. Metformin: Taking away the candy for cancer? Eur. J. Cancer 46 (2010), 2369-80
  2. Lee J.H., Kim T.I., Jeon S.M., Hong S.P., Cheon J.H., Kim W.H. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer. 131 (2012), 752-9
  3. Korsse S.E., Peppelenbosch M.P., van Veelen W. Targeting LKB1 signaling in cancer. Biochim. Biophys. Acta. 1835 (2013), 194-210
  4. Giles E.D., Jindal S., Wellberg E.A., Schedin T., Anderson S.M., Thor A.D., et al. Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer. Breast Cancer Res. 14 (2018), 50
  5. Heinz S., Freyberger A., Lawrenz B., Schladt L., Schmuck G., Ellinger-Ziegelbauer H. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart. Arch. Toxicol. 93 (2019), 2603-2615
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VEGA 1/0658/20 Combinatory treatment of glioblastom by temozolomid and lichen secondary metabolits - co-investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities
VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
IX. - Other relevant facts
IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Member of Council of study programm Zoology and Animal Physiology, master's degree

Member of Council of study programm Zoology and Animal Physiology, doctoral degree

Cooperation and study coordination for Ľ. Štúr Grammar School, Michalovce.

Erasmus students teaching (Animal Physiology, Animal and Human Ecophysiology).

h-index (Web of Science): 17 (August 2023)

Date of last update
2023-08-02